Search Results 101-110 of 3554 for 씨밀레토토

1. https://www.mayoclinic.org/patient_consumer_recipe.xml

2. A Phase 1 Study Evaluating The Safety, PK, And Clinical Effects Of PT-112 In Subjects With Advanced Solid Tumors

   The purpose of this study is to determine the maximum tolerated dose, and evaluate its safety, tolerability, preliminary clinical effects, and drug/body ...

3. Faculty and staff - Mayo Clinic Research

   See a list of faculty and staff for Mayo Clinic's Meningeal Lymphatics and Neurological Disorders Lab led by Sandro Da Mesquita, Ph.D.

4. Medical Research & Education - Mayo Clinic News Network

   The Children's Hospital at OU Medicine, Mayo Clinic announce collaboration on hypoplastic left heart syndrome. Terri Malloy. April 10, 2019. Research.

5. A Phase III, Prospective, Multicenter, Randomized, Controlled Clinical Trial To Demonstrate The Efficacy And Safety Of Liposomal Cyclosporine A (L-CsA) Inhalation Solution Delivered Via The PARI Investigational EFlow® Device Plus Standard Of Care Versus Standard Of Care Alone In The Treatment Of Chronic Lung Allograft Syndrome / Bronchiolitis Obliterans Syndrome In Patients Post Double Lung Transplantation (BOSTON-2) - Mayo Clinic

   A Phase III, Prospective, Multicenter, Randomized, Controlled Clinical Trial To Demonstrate The Efficacy And Safety Of Liposomal Cyclosporine A (L-CsA) ...

6. Telotristat ethyl (oral route) - Mayo Clinic

   Description. Telotristat ethyl is used in combination with somatostatin analog (SSA) therapy to treat carcinoid syndrome diarrhea.

7. Phase 2 Study To Evaluate The Oral Combination Of Ixazomib (MLN9708) With Cyclophosphamide And Dexamethasone In Patients With Newly Diagnosed Or Relapsed And/or Refractory Multiple Myeloma - Mayo Clinic

   About this study. This is a phase 2, multicenter, open-label study in patients with Newly Diagnosed Multiple Myeloma (NDMM) who have not received prior ...

8. Study Evaluating Efficacy And Safety Of Octagam 10% In Patients With Dermatomyositis (Idiopathic Inflammatory Myopathy) - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

9. A Study To Evaluate The Safety And Effectiveness Of Pembrolizumab Compared To Placebo In Resected High-risk Stage II Melanoma Patients - Mayo Clinic

   The purpose of this 2-part study is to evaluate the safety and effectiveness of pembrolizumab (MK-3475) compared to placebo in participants with surgically ...

10. A Study Of The Safety, Effectiveness And Maximum Tolerated Dose Of Oral PQR309 For Patients With Advanced Solid Tumors - Mayo Clinic

    The purpose of this study is to evaluate the safety, effectiveness and the maximum tolerable dose of PQR309 for the treatment of selected patients who have ...